131I labeling of tamoxifen and biodistribution studies in rats

Applied Radiation and Isotopes

Volumn 66, Issue 2, 2008, Pages 178-187

  Biber Muftuler, F Z ^a   Unak, P ^a   Teksoz, S ^a   Acar, C ^a   Yolcular, S ^a   Yurekli Y ^b  

^a EGE UNIVERSITY   (Turkey)

^b ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

131I; 131I TAM; Antiestrogen; Iodogen (1,3,4,6 tetrachloro 3 ,6 diphenylglycouril)

Indexed keywords

ANTIESTROGEN; BIODISTRIBUTION; MASS SPECTROSCOPY; OXIDIZING AGENTS; TAMOXIFEN;

DRUG PRODUCTS; ELECTROPHORESIS; MASS SPECTROMETRY; RADIOLOGY; RATS; TUMORS;

HORMONES;

DIPHENYL ETHER; IODINE 131; IODOTAMOXIFEN I 131; TAMOXIFEN; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG DISTRIBUTION; DRUG LABELING; DRUG STABILITY; ELECTROPHORESIS; FEMALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; RAT; SCINTIGRAPHY; TISSUE DISTRIBUTION; ANIMAL; BLOOD; BREAST TUMOR; HUMAN; IN VITRO STUDY; SCINTISCANNING; WISTAR RAT;

ANIMALS; BREAST NEOPLASMS; FEMALE; HUMANS; IODINE RADIOISOTOPES; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN; TISSUE DISTRIBUTION;

EID: 37149047201     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2007.08.005     Document Type: Article

References (32)

1. Chodak G.W., and Kolvenbag G.J.C.M. Will the experience with tamoxifen in breast cancer help define the role of antiandrogens in prostate cancer?. Prostate Cancer Prostatic Dis. 4 (2001) 72-80
2. Ciocca D.R., and Vargas L.M. Estrogen receptors in human nontarget tissues: biological and clinical implications. Endocrine Rev. 16 1 (1995) 35-62
3. Delpassand E.S., Yang D.G., Wallace S., Cherif A., Quadri S.M., Price G., Goubert A., Inoue T., and Podoloff D.A. Synthesis, biodistribution, and estrogen receptor scintigraphy of indium-111-diethyleneaminpentaacetic acid-tamoxifen analogue. J. Pharm. Sci. 85 (1996) 553-559
4. 123I-labeled tamoxifen metabolites in human plasma. Nucl. Med. Biol. 28 (2001) 335-338
5. Dugan E.M., Labib R.S., Anhalt G.J., and Diaz L.A. Selective surface radioiodination of keratinocytes in primary culture labels a 59 kD keratin and other surface proteins. Arch. Dermatol. Res. 281 (1989) 463-469
6. 131I-labeled estrone derivatives and biodistribution studies on rats. J. Radioanal. Nucl. Chem. 264 (2005) 535-539
7. Fabian C., Sternson L., El-serafi M., Cain L., and Hearne E. Clinical pharmacology of tamoxifen in patients with breast cancer: correlation with clinical data. Cancer 48 (1981) 876-882
8. Farah K., and Farouk N. Electrophilic radioiodination of tyrosine derivatives. J. Labelled Compd. Radiopharm. XLI (1998) 255-259
9. c-src. J. Biol. Chem. 266 28 (1991) I19040-I19046
10. Franker P.J., and Speck J.C. Protein and cell membrane iodinations with a sparinly soluble chloramide 1,3,4,6-tetrachloro 3α, 6α-diphenyl glycoluril. Biochem. Biophys. Res. Commun. 80 (1978) 849-857
11. Garg P.K., Alston K.L., Welsh P.C., and Zalutsky M.R. Enhanced binding and İnertness to dehalogenation of alpha-melanotropic peptides labeled using N-succinimdyl-3-iodobenzoate. Bioconjugate Chem. 7 (1996) 233-239
12. Heres-Pulido E.M., Duenas-Garcia I., Castaneda-Partida L., Sanchez-Garcia A., Contreras-Sousa M., Duran-Dias A., and Ulrich G. Genotoxicity of tamoxifen citrate and 4-nitroquinoline-1-oxide in the wing spot test drosophila melanogaster. Mutagenesis 19 (2004) 187-193
13. 99mtechnetium tamoxifen conjugates. Biocongugate Chem. 11 (2000) 175-181
14. Kedjouar B., Médina P., Oulad-Abdelghani M., Payré B., Silvente-Poirot S., Favre G., Faye J., and Poirot M. Molecular characterization of the microsomal tamoxifen binding site. J. Biol. Chem. 279 32 (2004) 34048-34061
15. Knight L.G., Budzynski A.Z., and Dexa S.A. Comparison of the iodogen and iodine monochloride methods for radioiodination of fibrinogen. J. Labelled Comp. Radiopharm. 18 1-2 (1981) 50-55
16. Kon O.L. An antiestrogen binding protein in human tissues. J. Biol. Chem. 258 5 (1983) 3173-3177
17. 123I-labeled 4-hydroxytamoxifen derivatives in rats with dimethylbenzanthracene-induced mammary carcinomas. Nucl. Med. Biol. 24 (1997) 719-722
18. Lashley M.R., Niedzinski E.J., Rogers J.M., Denison M.S., and Nantz M.H. Synthesis and estrogen receptor affinity of a 4-hydroxytamoxifen-labeled ligand for diagnostic imaging. Bioorg. Med. Chem. 10 (2002) 4075-4082
19. Marcsek Z., Kocsis Z., Jakab M., Szende B., and Tompa A. The efficacy of tamoxifen in estrogen receptor-positive breast cancer cells is enhanced by a medical nutriment. Cancer Biotherapy Radiopharm. 19 (2004) 746-753
20. Martin E.A., Brown K., Gaskell M., Al-Azzawi F., Garner R.C., Boocock D.J., Mattock E., Pring D.W., Dingley K., Turteltaub K.W., Smith L.L., and White I.N.H. Tamoxifen DNA damage detected in human endometrium using accelerator mass spectrometry. Cancer Res. 63 (2003) 8461-8465
21. Mihailescu R., Aboul-Enein H.Y., and Efstatide M.D. Identification of tamoxifen and metabolites in human male urine by GC/MS. Biomed. Chromatogr. 14 (2000) 180-183
22. O'Donoghue J.A., Bardies M., and Wheldon T.E. Relationship between tumor size and curability for targeted radionuclide therapy. J. Nucl. Med. 36 (1995) 1902-1909
23. 125I synkavit by the iodogen method. Chem. Lett. 187 4 (1994) 277-283
24. 125I](Z)-3-methoxy-17α-iodovinylestra-1,3,5(10),6-tetraen-17β-ol. Appl. Radiat. Isot. 54 (2001) 227-239
25. Strickland L.A., Ponce Y.Z., Hunter D.H., Zabel P.L., Powe J.E., Morrissey G., Driedger A.A., and Chamberlain M.J. Amino and iodotamoxifens: synthesis estrogen receptor affinity and biodistribution. Drug Des. Delivery 6 (1990) 195-212
26. 131I. Appl. Radiat. Isot. 62 (2005) 861-869
27. Ünak T., Akgün Y., Duman Y., and Erenel G. Self-radioiodination of iodogen. Appl. Radiat. Isot. 54 5 (2001) 749-752
28. Van Den Bosshe B., and Van de Wiele C. Receptor imaging in oncology by means of nuclear medicine: current status. J. Clin. Oncol. 22 (2004) 3593-3607
29. Van De Wiele C., Cocquyt V., VanddenBroecke R., De Vos P., Van Belle S., Dhaene K., Slegers G., and Diercks R.A. Iodine labeled tamoxifen uptake in primary human breast carcinoma. J. Nucl. Med. 42 (2001) 1818-1820
30. Winborn W.B., Sheridan P.J., and McGill H.C. Sex steroid in the stomach, liver, pancreas, and gastrointestinal tract of the baboon. Gastroenterology 92 1 (1987) 23-32
31. Winneker R.C., and Clark J.H. Estrogenic stimulation of the antiestrogen specific binding site in rat uterus and liver. Endocrinology 112 (1983) 1910-1915
32. Young H., Carnochan P., Trivedi M., Potter G.A., Eccles S.A., Haynes B.P., Jarman M., and Ott R.J. Pharmacokinetics and biodistribution of radiolabeled idoxifene prospects for the use of pet in the evaluation of a novel anti estrogen for cancer therapy. Nucl. Med. Biol. 22 (1995) 405-411